These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31825626)

  • 1. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial Release of Cisplatin from Triggerable Liposomes Enhances Efficacy against Triple Negative Breast Cancer Solid Tumor Analogues.
    Stras S; Holleran T; Howe A; Sofou S
    Mol Pharm; 2016 Sep; 13(9):3224-33. PubMed ID: 27482716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases.
    Prasad A; Nair R; Bhatavdekar O; Howe A; Salerno D; Sempkowski M; Josefsson A; Pacheco-Torres J; Bhujwalla ZM; Gabrielson KL; Sgouros G; Sofou S
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4246-4258. PubMed ID: 34117896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin.
    Salerno D; Sofou S
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
    Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
    Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
    J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer.
    Wan X; Liu C; Lin Y; Fu J; Lu G; Lu Z
    Drug Deliv; 2019 Dec; 26(1):470-480. PubMed ID: 30957572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer.
    Wan X; Zheng X; Pang X; Zhang Z; Jing T; Xu W; Zhang Q
    Int J Pharm; 2015 Apr; 484(1-2):16-28. PubMed ID: 25700543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Microenvironment-Sensitive Liposomes Penetrate Tumor Tissue via Attenuated Interaction of the Extracellular Matrix and Tumor Cells and Accompanying Actin Depolymerization.
    Suzuki S; Itakura S; Matsui R; Nakayama K; Nishi T; Nishimoto A; Hama S; Kogure K
    Biomacromolecules; 2017 Feb; 18(2):535-543. PubMed ID: 28055201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
    Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
    Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy.
    Mooney R; Weng Y; Garcia E; Bhojane S; Smith-Powell L; Kim SU; Annala AJ; Aboody KS; Berlin JM
    J Control Release; 2014 Oct; 191():82-9. PubMed ID: 24952368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
    Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
    Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer.
    Liu M; Ma W; Zhao D; Li J; Li Q; Liu Y; Hao L; Lin Y
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25825-25835. PubMed ID: 34038071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting.
    Zhu C; Sempkowski M; Holleran T; Linz T; Bertalan T; Josefsson A; Bruchertseifer F; Morgenstern A; Sofou S
    Biomaterials; 2017 Jun; 130():67-75. PubMed ID: 28365545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
    He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
    J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer.
    De Vita A; Liverani C; Molinaro R; Martinez JO; Hartman KA; Spadazzi C; Miserocchi G; Taraballi F; Evangelopoulos M; Pieri F; Bongiovanni A; Mercatali L; Tasciotti E; Ibrahim T
    Sci Rep; 2021 Mar; 11(1):5107. PubMed ID: 33658580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.